BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23297816)

  • 21. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.
    Aisyah DN; Shallcross L; Hayward A; Aldridge RW; Hemming S; Yates S; Ferenando G; Possas L; Garber E; Watson JM; Geretti AM; McHugh TD; Lipman M; Story A
    J Viral Hepat; 2018 Nov; 25(11):1260-1269. PubMed ID: 29851232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
    Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
    Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.
    Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J;
    J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment.
    Azbel L; Polonsky M; Wegman M; Shumskaya N; Kurmanalieva A; Asanov A; Wickersham JA; Dvoriak S; Altice FL
    Int J Drug Policy; 2016 Nov; 37():9-20. PubMed ID: 27455177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky.
    Stone J; Fraser H; Young AM; Havens JR; Vickerman P
    Int J Drug Policy; 2021 Feb; 88():102707. PubMed ID: 32151496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden.
    Tarján A; Dudás M; Wiessing L; Horváth G; Rusvai E; Tresó B; Csohán Á
    Int J Drug Policy; 2017 Mar; 41():1-7. PubMed ID: 27984762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates.
    Niriella MA; Hapangama A; Luke HP; Pathmeswaran A; Kuruppuarachchi KA; de Silva HJ
    Ceylon Med J; 2015 Mar; 60(1):18-20. PubMed ID: 25804913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study.
    Moradi G; Mohamadi P; Zareie B; Rasouli MA; Gouya MM; Jafari S
    BMC Infect Dis; 2020 Oct; 20(1):806. PubMed ID: 33129259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study.
    Champion JK; Taylor A; Hutchinson S; Cameron S; McMenamin J; Mitchell A; Goldberg D
    Am J Epidemiol; 2004 Mar; 159(5):514-9. PubMed ID: 14977648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of hepatitis C virus infection in the prison setting: The SToP-C study.
    Hajarizadeh B; Carson JM; Byrne M; Grebely J; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Lloyd AR; Dore GJ;
    J Viral Hepat; 2024 Jan; 31(1):21-34. PubMed ID: 37936544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug use and risk of bloodborne infections: a survey of female prisoners in British Columbia.
    Martin RE; Gold F; Murphy W; Remple V; Berkowitz J; Money D
    Can J Public Health; 2005; 96(2):97-101. PubMed ID: 15850026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
    Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of Novel Psychoactive Substance injecting associated with rapid rise in the population prevalence of hepatitis C virus.
    McAuley A; Yeung A; Taylor A; Hutchinson SJ; Goldberg DJ; Munro A
    Int J Drug Policy; 2019 Apr; 66():30-37. PubMed ID: 30690222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison.
    Bird AG; Gore SM; Hutchinson SJ; Lewis SC; Cameron S; Burns S
    BMJ; 1997 Jul; 315(7099):21-4. PubMed ID: 9233321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. History of detention and the risk of hepatitis C among people who inject drugs in Germany.
    Gassowski M; Nielsen S; Bannert N; Bock CT; Bremer V; Ross RS; Wenz B; Marcus U; Zimmermann R;
    Int J Infect Dis; 2019 Apr; 81():100-106. PubMed ID: 30658167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.
    Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ;
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):533-546. PubMed ID: 33965006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
    Turner KM; Hutchinson S; Vickerman P; Hope V; Craine N; Palmateer N; May M; Taylor A; De Angelis D; Cameron S; Parry J; Lyons M; Goldberg D; Allen E; Hickman M
    Addiction; 2011 Nov; 106(11):1978-88. PubMed ID: 21615585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities.
    Hellard ME; Hocking JS; Crofts N
    Epidemiol Infect; 2004 Jun; 132(3):409-15. PubMed ID: 15188710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of injecting and sharing in a Scottish prison.
    Shewan D; Macpherson A; Reid MM; Davies JB
    Drug Alcohol Depend; 1995 Oct; 39(3):237-43. PubMed ID: 8556973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.